$-0.16
(Market cap
$6,416 Mln
Recently Viewed
Clear AllMarket cap
$6,416 Mln
Revenue (TTM)
$2,348 Mln
P/E Ratio
55.2
P/B Ratio
11.9
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
0.3 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
43.5
Debt to Equity
2.3
Book Value
$2.2
EPS
$0.5
Face value
--
Shares outstanding
219,561,143
CFO
$-120.20 Mln
EBITDA
$-284.91 Mln
Net Profit
$-287.06 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Hims Hers Health Inc (HIMS)
| -19.4 | 35.0 | -8.7 | -25.3 | 31.2 | 16.4 | -- |
|
BSE Sensex
| -9.2 | 6.9 | -6.5 | -4.2 | 8.0 | 9.1 | 11.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Hims Hers Health Inc (HIMS)
| 34.3 | 169.5 | 38.8 | -2.1 | -55.1 | 47.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Hims Hers Health Inc (HIMS)
|
26.2 | 6,416.5 | 2,347.6 | 128.4 | 4.5 | 25.2 | 55.2 | 11.9 |
| 14.0 | 3,243.9 | 3,125.0 | -262.7 | 0.9 | -313.2 | -- | 20.5 | |
| 423.7 | 5,648.7 | 2,540.6 | 259.8 | 10.4 | 27 | 23 | 5.2 | |
| 57.1 | 2,938.0 | 941.5 | 105.7 | 14.5 | 29.4 | 28.1 | 7.8 | |
| 101.2 | 10,138.5 | 5,935.2 | 566.2 | 18.1 | 25.1 | 18.4 | 4.2 | |
| 18.7 | 4,443.1 | 5,649.5 | 207.6 | 7.0 | 15.2 | 22.4 | 3.4 | |
| 24.6 | 2,994.9 | 2,122.8 | 22.9 | 1.8 | 3.3 | 132.4 | 4.1 | |
| 55.3 | 4,510.8 | 2,040.2 | -18.7 | 5.0 | -1.9 | -- | 4.1 | |
| 15.5 | 4,442.7 | 1,163.6 | 78.0 | 26.1 | 15.4 | 57.7 | 7.3 | |
| 183.7 | 11,049.6 | 5,057.8 | 344.0 | 9.2 | 16.9 | 32.3 | 5.0 |
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and... internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California. Read more
Co-Founder, Chairman & CEO
Mr. Andrew Dudum
Co-Founder, Chairman & CEO
Mr. Andrew Dudum
Headquarters
San Francisco, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Hims Hers Health Inc (HIMS) is $26.17 (NYSE) as of 30-Apr-2026 10:44 EDT. Hims Hers Health Inc (HIMS) has given a return of 31.19% in the last 3 years.
The P/E ratio of Hims Hers Health Inc (HIMS) is 55.20 times as on 24-Apr-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
62.76
|
14.89
|
|
2024
|
46.18
|
12.21
|
|
2023
|
-79.28
|
5.43
|
|
2022
|
-20.12
|
4.24
|
|
2021
|
-12.25
|
3.94
|
The 52-week high and low of Hims Hers Health Inc (HIMS) are Rs 70.43 and Rs 13.75 as of 30-Apr-2026.
Hims Hers Health Inc (HIMS) has a market capitalisation of $ 6,416 Mln as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Hims Hers Health Inc (HIMS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.